Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates

Journal of Chemotherapy

Volumn 21, Issue 2, 2009, Pages 234-235

  Castagnola, E ^a   Franceschi, A ^a   Natalizia, A R ^a   Mantero, E ^a   Tuo, P ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN;

BLOOD CULTURE; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; DISEASE COURSE; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FOLLOW UP; FUNGUS ISOLATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; INFANT FEEDING; LETTER; PATENT DUCTUS ARTERIOSUS; PERSISTENT INFECTION; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; VASCULAR ACCESS;

EID: 67249135034     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.2.234     Document Type: Letter

References (17)

1. Benjamin DK, Jr., Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neu-rodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006; 117(l):84-92
2. Zaoutis T, Heydon K, Localio R, Walsh T, Feudtner C. Outcomes attributable to neonatal candidiasis. Clin Infect Dis. 2007; 44 (9): 1187-1193
3. Manzoni P, Farina D, Leonessa M, d'Oulx E, Galletto P, Mostert M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics. 2006; 118(6):2359-2364
4. Mermel L, Farr B, Sherertz R, Raad I, O'Grady N, Harris J, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32 (9): 1249-1272
5. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis. 2002; 34 (5):591-599
6. Benjamin DK, Jr., Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics. 2003; 112 (3 Pt l):634-640
7. Castagnola E, Marazzi MG, Tacchella A, Giacchino R. Broviac catheter-related candidemia. Pediatr Infect Dis J. 2005; 24 (8):747
8. Juster-Reicher A, Flidel-Rimon O, Amitay M, Even-Tov S, Shinwell E, Leibovitz E. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates. Eur J Clin Mi-crobiol Infect Dis. 2003; 22 (10):603-607
9. Comely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007; 44 (10): 1289-1297
10. Cuenca-Estrella M. Combinations of antifungal agents in therapy what value are they? J Antimicrob Chemother. 2004; 54 (5):854-869
11. Manzar S, Kamat M, Pyati S. Caspofungin for refractory candidemia in neonates. Pediatr Infect Dis J. 2006; 25 (3):282-283
12. Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Al-faro B, et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J. 2004; 23 (12): 1093-1097
13. Juster-Reicher A, Leibovitz E, Linder N, Amitay M, Flidel-Rimon O, Even-Tov S, et al. Liposomal amphotericin B (AmBi-some) in the treatment of neonatal candidiasis in very low birth weight infants. Infection. 2000; 28 (4):223-226
14. Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Be-dard M. Experience with caspofungin in the treatment of persistent fungemia in neonates. J Perinatol. 2005; 25 (12):770-777
15. Cetin H, Yalaz M, Akisu M, Hilmioglu S, Metin D, Kul-tursay N. The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia. Pediatr Int. 2005; 47 (6):676-680
16. Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cor-donnier C, Segal BH, et al. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer. 2006; 107 (12):2888-2897
17. Cesaro S, Giacchino M, Locatelli F, Spiller M, Buldini B, Castellini C, et al. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. BMC Infect Dis. 2007; 7 (1):28